These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 15238509)

  • 1. Localization of 4q35.2 to the nuclear periphery: is FSHD a nuclear envelope disease?
    Masny PS; Bengtsson U; Chung SA; Martin JH; van Engelen B; van der Maarel SM; Winokur ST
    Hum Mol Genet; 2004 Sep; 13(17):1857-71. PubMed ID: 15238509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation of the FSHD syndrome-linked subtelomeric repeat in normal and FSHD cell cultures and tissues.
    Tsien F; Sun B; Hopkins NE; Vedanarayanan V; Figlewicz D; Winokur S; Ehrlich M
    Mol Genet Metab; 2001 Nov; 74(3):322-31. PubMed ID: 11708861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation.
    Winokur ST; Chen YW; Masny PS; Martin JH; Ehmsen JT; Tapscott SJ; van der Maarel SM; Hayashi Y; Flanigan KM
    Hum Mol Genet; 2003 Nov; 12(22):2895-907. PubMed ID: 14519683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q.
    Jiang G; Yang F; van Overveld PG; Vedanarayanan V; van der Maarel S; Ehrlich M
    Hum Mol Genet; 2003 Nov; 12(22):2909-21. PubMed ID: 14506132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FRG2, an FSHD candidate gene, is transcriptionally upregulated in differentiating primary myoblast cultures of FSHD patients.
    Rijkers T; Deidda G; van Koningsbruggen S; van Geel M; Lemmers RJ; van Deutekom JC; Figlewicz D; Hewitt JE; Padberg GW; Frants RR; van der Maarel SM
    J Med Genet; 2004 Nov; 41(11):826-36. PubMed ID: 15520407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of allele-specific RNA transcription in FSHD by RNA-DNA FISH in single myonuclei.
    Masny PS; Chan OY; de Greef JC; Bengtsson U; Ehrlich M; Tawil R; Lock LF; Hewitt JE; Stocksdale J; Martin JH; van der Maarel SM; Winokur ST
    Eur J Hum Genet; 2010 Apr; 18(4):448-56. PubMed ID: 19888305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remodeling of the chromatin structure of the facioscapulohumeral muscular dystrophy (FSHD) locus and upregulation of FSHD-related gene 1 (FRG1) expression during human myogenic differentiation.
    Bodega B; Ramirez GD; Grasser F; Cheli S; Brunelli S; Mora M; Meneveri R; Marozzi A; Mueller S; Battaglioli E; Ginelli E
    BMC Biol; 2009 Jul; 7():41. PubMed ID: 19607661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy.
    Osborne RJ; Welle S; Venance SL; Thornton CA; Tawil R
    Neurology; 2007 Feb; 68(8):569-77. PubMed ID: 17151338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facioscapulohumeral muscular dystrophy. Phenotype-genotype correlation in patients with borderline D4Z4 repeat numbers.
    Butz M; Koch MC; Müller-Felber W; Lemmers RJ; van der Maarel SM; Schreiber H
    J Neurol; 2003 Aug; 250(8):932-7. PubMed ID: 12928911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolutionary genomic remodelling of the human 4q subtelomere (4q35.2).
    Bodega B; Cardone MF; Müller S; Neusser M; Orzan F; Rossi E; Battaglioli E; Marozzi A; Riva P; Rocchi M; Meneveri R; Ginelli E
    BMC Evol Biol; 2007 Mar; 7():39. PubMed ID: 17359533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable hypomethylation of D4Z4 in facioscapulohumeral muscular dystrophy.
    van Overveld PG; Enthoven L; Ricci E; Rossi M; Felicetti L; Jeanpierre M; Winokur ST; Frants RR; Padberg GW; van der Maarel SM
    Ann Neurol; 2005 Oct; 58(4):569-76. PubMed ID: 16178028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype-phenotype study in an FSHD family with a proximal deletion encompassing p13E-11 and D4Z4.
    Deak KL; Lemmers RJ; Stajich JM; Klooster R; Tawil R; Frants RR; Speer MC; van der Maarel SM; Gilbert JR
    Neurology; 2007 Feb; 68(8):578-82. PubMed ID: 17229919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A functional role for 4qA/B in the structural rearrangement of the 4q35 region and in the regulation of FRG1 and ANT1 in facioscapulohumeral dystrophy.
    Pirozhkova I; Petrov A; Dmitriev P; Laoudj D; Lipinski M; Vassetzky Y
    PLoS One; 2008; 3(10):e3389. PubMed ID: 18852887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypomethylation is restricted to the D4Z4 repeat array in phenotypic FSHD.
    de Greef JC; Wohlgemuth M; Chan OA; Hansson KB; Smeets D; Frants RR; Weemaes CM; Padberg GW; van der Maarel SM
    Neurology; 2007 Sep; 69(10):1018-26. PubMed ID: 17785671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 4q subtelomere harboring the FSHD locus is specifically anchored with peripheral heterochromatin unlike most human telomeres.
    Tam R; Smith KP; Lawrence JB
    J Cell Biol; 2004 Oct; 167(2):269-79. PubMed ID: 15504910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular diagnosis of facioscapulohumeral muscular dystrophy.
    Upadhyaya M; Cooper DN
    Expert Rev Mol Diagn; 2002 Mar; 2(2):160-71. PubMed ID: 11962336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Translocation between chromosomes 4q35 and 10q26 in facioscapulohumeral muscular dystrophy].
    Su QX; Zhang C; Zeng Y; Lu XL; Liu XR; Wang ZH; Zhu YZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):581-4. PubMed ID: 14650163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromatin loop domain organization within the 4q35 locus in facioscapulohumeral dystrophy patients versus normal human myoblasts.
    Petrov A; Pirozhkova I; Carnac G; Laoudj D; Lipinski M; Vassetzky YS
    Proc Natl Acad Sci U S A; 2006 May; 103(18):6982-7. PubMed ID: 16632607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical phenotypes in patients with facioscapulohumeral muscular dystrophy 4q35 deletion.
    Krasnianski M; Eger K; Neudecker S; Jakubiczka S; Zierz S
    Arch Neurol; 2003 Oct; 60(10):1421-5. PubMed ID: 14568813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new dosage test for subtelomeric 4;10 translocations improves conventional diagnosis of facioscapulohumeral muscular dystrophy (FSHD).
    van der Maarel SM; Deidda G; Lemmers RJ; Bakker E; van der Wielen MJ; Sandkuijl L; Hewitt JE; Padberg GW; Frants RR
    J Med Genet; 1999 Nov; 36(11):823-8. PubMed ID: 10544225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.